Higher CD69 expression on CD19+ B-cells was reported with longer survival in colorectal cancer (48).Understanding the complexity of the polarization of T- or B-cell subsets, myeloid cell types in response to ICI therapy is the focus of the current research. Here, CD69 is linked to colorectal cancer.